From 2018 which is interesting for those who are not up with the hstory of PTX-100 and 200. When SS references the results of the breast cancer trial, it is PTX-200. So, it'll be good to know if the AML trial results pique any interest as a farm out or as a combo drug given that switches of the AKT pathway in which leads to cancer growth. Things could get interesting if we get something out of left field!
Ann: PTX-100 abstract published online on ASH website, page-25
Add PTX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $35.43M | |||
| Open | High | Low | Value | Volume |
| 4.4¢ | 4.4¢ | 4.3¢ | $18.06K | 411.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 83871 | 4.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.5¢ | 55538 | 2 |
View Market Depth
| Last trade - 16.10pm 24/05/2024 (20 minute delay) ? |
|
|||||
|
Last
4.3¢ |
Change
0.000 ( 4.44 %) |
||||
| Open | High | Low | Volume | ||
| 4.4¢ | 4.4¢ | 4.3¢ | 151585 | ||
| Last updated 15.50pm 24/05/2024 ? | |||||
| PTX (ASX) Chart |